Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:399983
Who is this for?
Show terms as
3Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare male infertility due to hypothalamic-pituitary-gonadal (HPG) axis disorder of genetic origin is a condition where genetic changes disrupt the hormonal signaling system that controls male reproductive function. The HPG axis is a chain of communication between three parts of the body: the hypothalamus (a region in the brain), the pituitary gland (a small gland at the base of the brain), and the gonads (the testes in males). Normally, the hypothalamus releases a hormone called GnRH, which tells the pituitary gland to release two other hormones — LH and FSH — that signal the testes to produce testosterone and sperm. When genetic mutations interfere with any step in this chain, the result can be low testosterone levels, absent or delayed puberty, and an inability to produce sperm, leading to infertility. Key symptoms often include small testes, reduced or absent facial and body hair, low sex drive, erectile difficulties, and sometimes associated features like a reduced sense of smell (as seen in Kallmann syndrome, a well-known subtype). Some men may not realize they have this condition until they try to have children and discover they have very low or absent sperm counts. Treatment depends on the specific genetic cause but often involves hormone replacement therapy. Gonadotropin therapy (injections of LH and FSH or their analogs such as hCG and recombinant FSH) can stimulate the testes to produce sperm in many cases, especially when the problem originates in the hypothalamus or pituitary. Testosterone replacement can address symptoms of low testosterone but does not restore fertility on its own. With appropriate treatment, many men with this condition can achieve fatherhood, though outcomes vary depending on the underlying genetic defect.

Also known as:

Key symptoms:

Inability to father children (infertility)Very low or absent sperm countSmall or underdeveloped testesDelayed or absent pubertyReduced facial and body hairLow sex drive (low libido)Erectile dysfunctionDecreased muscle massIncreased body fatBreast tissue enlargement (gynecomastia)Low energy and fatigueReduced or absent sense of smell (in some subtypes)Mood changes or depressionUndescended testes at birth (in some cases)Decreased bone density over time

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Jan 2021The Molecular Basis of Inherited Reproductive Disorders

Stephanie B. Seminara, MD

TrialRECRUITING
Mar 2018Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing

Boston College

TrialACTIVE NOT RECRUITING
Mar 2012Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Centre Hospitalier Universitaire Vaudois

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Other3 trials
The Molecular Basis of Inherited Reproductive Disorders
Actively Recruiting
PI: Stephanie Seminara, MD (Massachusetts General Hospital) · Sites: Boston, Massachusetts · Age: 199 yrs
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Actively Recruiting
PI: Nelly Pitteloud, M.D. (Centre Hositalier Universitaire Vaudois (CHUV)) · Sites: Lausanne, Canton of Vaud
Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing
Active
PI: Andrew A Dwyer, PhD (Boston College) · Sites: Boston, Massachusetts; Chestnut Hill, Massachusetts · Age: 1870 yrs

No specialists are currently listed for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic originForum →

No community posts yet. Be the first to share your experience with Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin.

Start the conversation →

Latest news about Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin

No recent news articles for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic cause has been identified for my condition, and what does it mean for my health?,Is my type of HPG axis disorder likely to respond to gonadotropin therapy for fertility?,How long should I expect treatment to take before we can assess whether sperm production has been achieved?,Are there risks of passing this genetic condition to my future children, and should my family members be tested?,What are the long-term health risks if I have low testosterone, and how will we monitor for them?,What assisted reproductive options are available if gonadotropin therapy does not produce enough sperm?,Are there any clinical trials or new treatments being studied for my specific condition?

Common questions about Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin

What is Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin?

Rare male infertility due to hypothalamic-pituitary-gonadal (HPG) axis disorder of genetic origin is a condition where genetic changes disrupt the hormonal signaling system that controls male reproductive function. The HPG axis is a chain of communication between three parts of the body: the hypothalamus (a region in the brain), the pituitary gland (a small gland at the base of the brain), and the gonads (the testes in males). Normally, the hypothalamus releases a hormone called GnRH, which tells the pituitary gland to release two other hormones — LH and FSH — that signal the testes to produce

Are there clinical trials for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin?

Yes — 3 recruiting clinical trials are currently listed for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.